The Expression of Insulin-Like Growth Factor II Messenger RNA-Binding Protein 3 Upregulated in Intradural Extramedullary Schwannomas-Reference-Cited by-同舟云学术

The Expression of Insulin-Like Growth Factor II Messenger RNA-Binding Protein 3 Upregulated in Intradural Extramedullary Schwannomas

Published:2023-01-27 Issue:1 Volume:7 Page:36-41
ISSN:2432-261X
Container-title:Spine Surgery and Related Research
language:en
Short-container-title:Spine Surg Relat Res

Author:

Bekki Hirofumi¹,Matsumoto Yoshihiro¹,Yoshimoto Masato¹,Ishihara Shin¹,Kawaguchi Kenichi¹,Yamamoto Hidetaka²,Oda Yoshinao²,Nakashima Yasuharu¹,Harimaya Katsumi³

Affiliation:

1. Department of Orthopaedic Surgery, Graduate School of Medical Science, Kyushu University

2. Department of Anatomic Pathology, Graduate School of Medical Science, Kyushu University

3. Department of Orthopaedic Surgery, Kyushu University Beppu Hospital

Publisher

Japanese Society for Spine Surgery and Related Research

Subject

Neurology (clinical),Orthopedics and Sports Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/ssrr/7/1/7_2022-0063/_pdf

Reference21 articles.

1. 1. Antonescu CR, Perry A, Woodruff JM. Schwannoma. Lyon (France): IARC; 2013. WHO Classification of Tumours of Soft Tissue and Bone. p. 170-4.

2. 2. Harimaya K, Matsumoto Y, Kawaguchi K, et al. Clinical features of multiple spinal schwannomas without vestibular schwannomas. J Orthop Sci. 2021;23;S0949-2658 (21):00089-0.

3. 3. Hirayama M, Tomita Y, Yuno A, et al. An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. Oncoimmunology. 2016;5 (6):e1123368.

4. 4. Liao B, Hu Y, Brewer G. RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem. 2011;286 (36):31145-52.

5. 5. Jiang Z, Chu PG, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol. 2006;7 (7):556-64.